Palmer Robert B
University of Colorado School of Medicine, Denver, Colorado, USA.
Semin Diagn Pathol. 2009 Feb;26(1):18-27. doi: 10.1053/j.semdp.2008.12.005.
Ethyl glucuronide (EtG) is a direct phase-II metabolite of ethanol formed through the UDP-glucuronosyl transferase catalyzed conjugation of ethanol with glucuronic acid. It has been detected in many antemortem and postmortem biological matrices using a variety of analytical methods. Due to its long urinary elimination time, detectability in hair, specificity for ethanol exposure, and low detection limits of assays, the use of EtG has been proposed as a marker of recent ethanol intake in a variety of clinical and legal settings, including medical monitoring for relapse, emergency department patient evaluation, postmortem assessments, and transportation accident investigation. However, challenges associated with factors such as establishing appropriate cut-off levels capable of distinguishing between drinking and nonbeverage sources of ethanol exposure, nonuniform laboratory reporting limits, sample stability, and microbial activity substantially complicate accurate interpretation of results. The following review briefly explores the history, utility, and limitations of EtG in contemporary medical and forensic practice.
葡萄糖醛酸乙酯(EtG)是乙醇的一种直接II相代谢产物,通过尿苷二磷酸葡萄糖醛酸基转移酶催化乙醇与葡萄糖醛酸结合形成。使用多种分析方法已在许多生前和死后生物样本中检测到它。由于其在尿液中的消除时间长、在毛发中可检测、对乙醇暴露具有特异性以及检测方法的低检测限,EtG已被提议作为各种临床和法律环境中近期乙醇摄入的标志物,包括复发的医学监测、急诊科患者评估、死后评估以及交通事故调查。然而,与确定能够区分饮酒和非饮料来源乙醇暴露的适当临界值、实验室报告限值不统一、样本稳定性以及微生物活性等因素相关的挑战,极大地使结果的准确解释变得复杂。以下综述简要探讨了EtG在当代医学和法医学实践中的历史、用途和局限性。